Isofol announces start of study data analysis of phase III AGENT study in advanced metastatic colorectal cancer
GOTHENBURG, Sweden, April 22, 2022 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announcedthe start of data analysis of themulti-center, global Phase III AGENT Study inves...